NUTRALIFE BIOSCIENCES, INC. Proceeds from Common Stock Issued
NUTRALIFE BIOSCIENCES, INC. reported Proceeds from Common Stock Issued of $110.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2022-11-21
- NUTRALIFE BIOSCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- NUTRALIFE BIOSCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2021-12-31 was $0.00.
- NUTRALIFE BIOSCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2021-09-30 was $155.00K.
- NUTRALIFE BIOSCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2020-12-31 was $0.00.
- NUTRALIFE BIOSCIENCES, INC. proceeds from issuance of common stock for fiscal 2021 was $348.00K, a 178.40% increase from fiscal 2020.
- NUTRALIFE BIOSCIENCES, INC. proceeds from issuance of common stock for fiscal 2020 was $125.00K, a 95.51% decline from fiscal 2019.
- NUTRALIFE BIOSCIENCES, INC. proceeds from issuance of common stock for fiscal 2019 was $2.78M, a 349.86% increase from fiscal 2018.
- NUTRALIFE BIOSCIENCES, INC. proceeds from issuance of common stock for fiscal 2018 was $618.33K.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | $110.00K 10-Q · filed 2022-11-21 | |||
| 2022-06-30 | $110.00K 10-Q · filed 2022-08-22 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11 | $155.00K derived: sum of 2 quarters · filed 2022-11-21 | $348.00K 10-K · filed 2022-04-11 | ||
| 2021-09-30 | $155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | $348.00K 10-Q · filed 2022-11-21 | |||
| 2021-06-30 | $193.00K 10-Q · filed 2022-08-22 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11 | $0.00 derived: sum of 2 quarters · filed 2022-04-11 | $25.00K derived: sum of 3 quarters · filed 2022-04-11 | $125.00K 10-K · filed 2022-04-11 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $25.00K derived: sum of 2 quarters · filed 2021-11-15 | $125.00K 10-Q · filed 2021-11-15 | -$7.82K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $125.00K 10-Q · filed 2021-08-16 | -$7.82K derived: sum of 3 quarters · filed 2021-08-16 | $462.18K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $100.00K 10-Q · filed 2021-07-16 | -$32.82K derived: sum of 2 quarters · filed 2021-07-16 | $437.18K derived: sum of 3 quarters · filed 2021-07-16 | $657.18K derived: sum of 4 quarters · filed 2021-07-16 | |
| 2019-12-31 | -$132.82K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-24 | $337.18K derived: sum of 2 quarters · filed 2021-06-24 | $557.18K derived: sum of 3 quarters · filed 2021-06-24 | $2.78M 10-K · filed 2021-06-24 | |
| 2019-09-30 | $470.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-12 | $690.00K derived: sum of 2 quarters · filed 2021-05-12 | $2.91M 10-Q · filed 2021-05-12 | $3.49M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-06-30 | $220.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-22 | $2.44M 10-Q · filed 2021-04-22 | $3.02M derived: sum of 3 quarters · filed 2021-04-22 | ||
| 2019-03-31 | $2.22M 10-Q · filed 2021-04-12 | $2.80M derived: sum of 2 quarters · filed 2021-04-12 | |||
| 2018-12-31 | $575.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $618.33K 10-K · filed 2021-03-19 | |||
| 2018-09-30 | $43.33K 10-Q · filed 2019-11-14 | ||||
| 2018-08-31 | $43.33K 10-K · filed 2019-04-03 | ||||
| 2017-02-28 | $5.00K 10-K · filed 2019-04-03 |